339151-88-1 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 2-chloro-4,6-diMethylnicotinate is used as a therapeutic agent for the treatment of neurological disorders due to its ability to stimulate nicotinic acetylcholine receptors, which may help in managing such conditions.
Used in Agricultural Industry:
In the agricultural sector, Methyl 2-chloro-4,6-diMethylnicotinate is utilized as a pesticide for crop protection, leveraging its potential effects on pests to ensure healthier and more productive crops.
Used in Medicinal Development:
Methyl 2-chloro-4,6-diMethylnicotinate is of interest in the development of new medications, particularly for its potential anti-inflammatory and analgesic properties, which could be beneficial in treating pain and inflammation-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 339151-88-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,9,1,5 and 1 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 339151-88:
(8*3)+(7*3)+(6*9)+(5*1)+(4*5)+(3*1)+(2*8)+(1*8)=151
151 % 10 = 1
So 339151-88-1 is a valid CAS Registry Number.
InChI:InChI=1S/C9H10ClNO2/c1-5-4-6(2)11-8(10)7(5)9(12)13-3/h4H,1-3H3
339151-88-1Relevant academic research and scientific papers
PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS
-
Page/Page column 51, (2020/12/07)
The present disclosure is directed to pyridinone derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV nave cells, and for the treatment of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).
Enantioselective total synthesis of a potent antitumor antibiotic, fredericamycin A
Kita,Higuchi,Yoshida,Iio,Kitagaki,Ueda,Akai,Fujioka
, p. 3214 - 3222 (2007/10/03)
The asymmetric total synthesis of both enantiomers of the potent antitumor antibiotic fredericamycin A (1) is detailed based on the protocol for the construction of its peri-hydroxy polyaromatic skeleton bearing the chirality at the spiro carbon via a str
